• About
  • Services
  • Clients
  • Client News
  • PCG Research
  • PCG Digital
  • Contact
  • follow:

  • 9 Nov

    Bionik Laboratories Reports Second Quarter Fiscal Year 2023 Financial Results

    Launch of Centers of Excellence Strategy Increases Outlook for Growth BOSTON, November 09, 2022--(BUSINESS WIRE)--Bionik Laboratories Corp. (OTCPINK: BNKL), a robotics company providing neurological functional recovery solutions to stroke survivors and others with functional and mobility challenges, today reported financial results for the second quarter of fiscal year 2023, ended… Read More..

    Share this:
  • 8 Nov

    Auddia Inc. Announces Corporate Update Call and Webcast on November 15th

    Auddia Inc. Announces Corporate Update Call and Webcast on November 15th Auddia Inc. Tue, November 8, 2022, 7:00 AM·1 min read In this article: AUUD -3.64% BOULDER, CO, Nov. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Auddia Inc. (NASDAQ: AUUD) (NASDAQ: AUUDW) ("Auddia" or the "Company”), developer of a… Read More..

    Share this:
  • 8 Nov

    Lexaria Starts Study Evaluating the Effect of DehydraTECH-CBD on Diabetes

    KELOWNA, BC / ACCESSWIRE / November 8, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that study program DIAB-A22-1 is expected to begin on schedule today. This is Lexaria's first-ever study to investigate whether its patented DehydraTECH-processed cannabidiol ("CBD") may… Read More..

    Share this:
« Previous 1 … 186 187 188 189 190 … 239 Next »
  • Twitter feed is not available at the moment.
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client News
    • PCG Research
    • PCG Digital
    • Contact